No Data
Institutional Investors May Adopt Severe Steps After CRISPR Therapeutics AG's (NASDAQ:CRSP) Latest 8.3% Drop Adds to a Year Losses
SA Asks: Which Big Pharmas Are Likely to Announce Big M&A Deals?
JMP Securities Maintains CRISPR Therapeutics(CRSP.US) With Buy Rating, Maintains Target Price $86
CRISPR Therapeutics: Promising Developments and Positive Outlook Amid Advancements in Gene-Editing
1 Big New Green Flag for CRISPR Therapeutics' Stock
Express News | JMP Securities Reiterates Market Outperform on CRISPR Therapeutics, Maintains $86 Price Target
10baggerbamm : if you get her updates she's been aggressively buying the stock.. and she was a buyer this week.
Kim10 OP 10baggerbamm : interesting to see her trim tesla and buy this all we need now is for cramer to recommend this
10baggerbamm Kim10 OP : that's the problem with Kathy Woods.. she has these grandiose projections on Tesla Optimus 27 trillion in revenue to make every TV camera go her way she gets on Bloomberg and CNBC and Fox Business and then what does she do she dumps Tesla stock she sells palantir stock and she buys ....train wrecks. she's looking for turnarounds so she sells winners and buys short-term problematic fundamentally or technical challenge companies.
Kim10 OP 10baggerbamm : she's here for a good time not a long time who gives a flying fuck abt the shareholders amiright
10baggerbamm Kim10 OP : I think the reason for her selling her winners Tesla palantir is she doesn't have the inflows anymore coming in or she has the ability to continuously put money to work I think because of her shit performance the fact that she's lagged so horrifically the S&P 500 money has left her portfolio of funds her basket of funds and this hurts her ability more than anything else so she's forced to sell winners and buy turnarounds with those monies.. if she had the amount of inflows like she had several years ago I don't believe you would see her selling her Tesla's, pltr and companies like that